A Comparison of Regional Decisions for Doses and Administrations of New Drugs: Concordance, Discordance, and Dependencies

Documenti analoghi

• Dose Determinations at Drug Approval Reviews: FDA‐Approved Drugs in Past 5 Years
  di: Sachiko Mita, et al.
  Pubblicazione: (2025)
• Background Factors Contributing to Safety Warning Discordance in the Initial Labeling of New Drugs in Japan, the United States, and the European Union
  di: Koichi Fukuda, et al.
  Pubblicazione: (2024)
• Assessment of Dosing Strategies for Pediatric Drug Products
  di: Zachary L. Taylor, et al.
  Pubblicazione: (2024)
• Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012–2021
  di: Yoona Choi, et al.
  Pubblicazione: (2025)
• Trust in the Food and Drug Administration: A National Survey Study
  di: William B. Feldman, et al.
  Pubblicazione: (2024)